CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group BMI, Infarct Size, and Clinical Outcomes Following Primary PCI Patient-Level Analysis From 6 Randomized Trials Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement Evaluation and Management of Nonculprit Lesions in STEMI Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI A randomised trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trial High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary Syndrome New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial Imaging Coronary Anatomy and Reducing Myocardial Infarction Chronic total occlusion intervention of the non-infarct-related artery in acute myocardial infarction patients: the Korean multicenter chronic total occlusion registry
|<<... 10 11 12 13 14 15 16 ...>>|

Original ResearchVolume 13, Issue 11, June 2020

JOURNAL：JACC: Cardiovascular Interventions Article Link

Percutaneous Coronary Intervention for Chronic Total Occlusion—The Michigan Experience: Insights From the BMC2 Registry

H Othman, M Seth on behalf of the BMC2 Investigators. Keywords: CTO; angina; procedural risk; periprocedural major adverse cardiac events; mortality

ABSTRACT

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top